University Of Cologne
University Of Cologne is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
Randomized Controlled Trial Assessing the Effectiveness and Safety of Fecal Microbiota Transfer for VRE Eradication in Immunocompromised Patients (EU CTR, Phase II) – VRE-ex
Sponsor Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
- Not reported
A combined phase I/IIa trial to investigate the safety and pharmacokinetics of StaphAcute in healthy participants and patients with Staphylococcus aureus bacteremia - StaphAcute
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
- Not reported
Daratumumab for first line treatment of transplant-ineligible myeloma patients followed by daratumumab re-treatment at first relapse (GMMG-DADA)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase I safety, dose finding and feasibility trial of MB-CART19.1 in patients with relapsed or refractory CD19 positive B cell malignancies
Sponsor Miltenyi Biomedicine GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for University Of Cologne?
The 2026-10-09 snapshot links University Of Cologne to 5 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Clinical monitoring, Data management, Electronic data capture, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for University Of Cologne?
The most frequently recorded therapeutic areas are Infectious Disease, Musculoskeletal. Recorded phases include Phase 2, Phase 1, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to University Of Cologne conducted?
The linked trials record locations in 1 country, including Germany. These are trial locations, not confirmed office locations or countries where University Of Cologne delivered services.
What can this page tell me about University Of Cologne's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under University Of Cologne. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- University Of Cologne